Latest Press Releases
View all
TimeHeadline
37m agoEpsium Enterprise Limited Files Annual Report on Form 20-F for Fiscal Year 2025
1h agoNewmark Names Jack Fuchs as President of Global Asset Services and Member of the Executive Committee
1h agoStop the Rail Merger Coalition Launches to Oppose Union Pacific-Norfolk Southern Merger
1h agoNorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2026
1h agoBetter Home Equity Card Powered by Stripe Enables Easy Access to HELOC Funds and Introduces a Modern Access Layer Across the $21.4 Trillion Home Equity Market

Hanmi Pharm Co Ltd

About

Hanmi Pharm Co Ltd (KO:128940) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 13 2026
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Feb 24 2026
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
Jan 28 2026
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
Dec 19 2025
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
Nov 19 2025
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

Financials

Revenue
₩1.46 T
Market Cap
₩6.34 T
Dividend Yield
0.40%

Community Chat

Ask AI

6ix6ix